Tag Archives: MEI Pharma

August, 2016

March, 2015

  • 23 March

    MEI Pharma’s Lead Cancer Drug Fails in Phase II Study

    MEI Pharma’s lead cancer drug failed to meet the primary goal in a mid-stage study, causing shares to drop to a 52-week low. The company announced top-line data from a Phase II clinical trial evaluating its investigational drug candidate Pracinostat in combination with azacitidine in patients with previously untreated intermediate-2 …